The Life Science Instrumentation market is the largest instrumentation segment, accounting for nearly a quarter of the global market.
This segment consists of following 13 technology segments with a wide range of applications that leave significant opportunities for discovery, innovation, and expansion for general applications as well as niche research markets:
- NA Sequencing
- Capillary Electrophoresis
- Nucleic Acid Prep and Cell Separation
- SPR and Label-Free Detection
- Flow Cytometry
- High Content Analysis/Cell Imaging
- Automated Synthesizers
- In Vivo Animal Imaging
- Cell Counters
This market is expected to increase at a solid average rate of 5.7% over the next five years. This relatively high overall growth is mostly led by DNA Sequencing instrumentation, as technological innovations pave the way for increasingly personalized medicine. Next-generation sequencing (NGS) has been the single-largest driver of growth among all life sciences technologies.
Although nucleic acid sample preparation and cell separation will see relatively slow growth compared to other technologies, the markets for those still remain very large because of how essential they are for innumerable downstream applications.
This section is directly extracted from the 2019 Global Assessment Report: The Analytical and Life Science Instrumentation Industry, published February 2019.
Life Science Instrumentation Product Category Coverage
|DNA Sequencing||PCR||Microarrays||Nucleic Acid Sample Prep And Cell Separation||Electrophoresis||Capillary Electrophoresis||In Vivo Animal Imaging||Flow Cytometry||Cell Counters||Electrophysiology||High Content Analysis/Cell Imaging||SPR and Label-Free Detection||Automated Synthesizers|
|Key Market Dynamics|